Literature DB >> 15645232

Effectiveness of colchicine in a case of recurrent compressive rheumatoid pericarditis.

Pascal Sève1, Katia Stankovic, Christiane Broussolle.   

Abstract

Survival is impaired in rheumatoid pericarditis complicated by cardiac compression by either tamponade or constriction. Conventional therapy with non-steroidal anti-inflammatory agents and glucocorticoids is frequently ineffective in reversing severe cardiac impairment and/or in preventing recurrences. Colchicine, an effective and safe treatment of idiopathic and post-viral pericarditis, has not been studied in rheumatoid pericarditis. We describe the case of a 44-year-old woman with a 1-year history of rheumatoid arthritis who developed rheumatoid pericarditis complicated with tamponade. Pericardiocentesis relieved the symptoms, but pericarditis recurred at a high dose of prednisone of 70 mg/day. Colchicine at a dose of 1 mg/day prevented recurrences and had a significant sparing effect on steroids, which were reduced to 6 mg/day. This is the second case report describing the effectiveness of colchicine therapy in rheumatoid pericarditis complicated with tamponade. These cases suggest that colchicine should be considered in the treatment of rheumatoid pericarditis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15645232     DOI: 10.1007/s00296-004-0572-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  12 in total

Review 1.  Cardiac involvement in rheumatoid disease.

Authors:  G Kitas; M J Banks; P A Bacon
Journal:  Clin Med (Lond)       Date:  2001 Jan-Feb       Impact factor: 2.659

2.  Rheumatoid pericarditis: clinical features and survival.

Authors:  K S Hara; D J Ballard; D M Ilstrup; D C Connolly; R S Vollertsen
Journal:  Medicine (Baltimore)       Date:  1990-03       Impact factor: 1.889

3.  Recurrent pericarditis and cardiac tamponade in rheumatoid arthritis: effectiveness of colchicine.

Authors:  J Fernández-Muixí; F Vidal; A Bardají; C Richart
Journal:  Br J Rheumatol       Date:  1994-06

4.  Recurrent pericarditis. Relief with colchicine.

Authors:  J Guindo; A Rodriguez de la Serna; J Ramió; M A de Miguel Diaz; M T Subirana; M J Perez Ayuso; J Cosín; A Bayés de Luna
Journal:  Circulation       Date:  1990-10       Impact factor: 29.690

Review 5.  Update on colchicine and its mechanism of action.

Authors:  Yair Molad
Journal:  Curr Rheumatol Rep       Date:  2002-06       Impact factor: 4.592

6.  Treatment of recurrent pericarditis with colchicine.

Authors:  A Millaire; P de Groote; E Decoulx; L Goullard; G Ducloux
Journal:  Eur Heart J       Date:  1994-01       Impact factor: 29.983

7.  Management of a patient with active rheumatoid arthritis and suspected tuberculosis causing effusive-constrictive pericarditis.

Authors:  Mustafa Yildiz; Okan Erdogan; Meryem Aktoz; Cetin Gul; Gultac Ozbay
Journal:  Int J Cardiol       Date:  2003-05       Impact factor: 4.164

8.  Cardiac compression in rheumatoid pericarditis.

Authors:  A Escalante; R L Kaufman; F P Quismorio; T D Beardmore
Journal:  Semin Arthritis Rheum       Date:  1990-12       Impact factor: 5.532

9.  Fatal outcome of constrictive pericarditis in rheumatoid arthritis.

Authors:  Peter Härle; Bernd Salzberger; Thomas Glück; Jürgen Schölmerich; Ulf Müller-Ladner
Journal:  Rheumatol Int       Date:  2003-09-10       Impact factor: 2.631

10.  Rheumatoid pericarditis: new immunopathological aspects.

Authors:  A Travaglio-Encinoza; J M Anaya; A D Dupuy D'Angeac; T Rème; J Sany
Journal:  Clin Exp Rheumatol       Date:  1994 May-Jun       Impact factor: 4.473

View more
  1 in total

Review 1.  Colchicine as a Potential Therapeutic Agent Against Cardiovascular Complications of COVID-19: an Exploratory Review.

Authors:  Christodoulos Papadopoulos; Dimitrios Patoulias; Eleftherios Teperikidis; Dimitrios Mouselimis; Anastasios Tsarouchas; Maria Toumpourleka; Aristi Boulmpou; Constantinos Bakogiannis; Michael Doumas; Vassilios P Vassilikos
Journal:  SN Compr Clin Med       Date:  2020-08-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.